spacer
home > epc > Winter 2018
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2018

   
Text
PDF
bullet
Central Labs
Good Laboratory Practices

Ticking Boxes

Having a comprehensive checklist of Good Laboratory Practices within immuno-oncology trials can simplify study processes, as Elizabeth Koury and Jeff Mayhew at LabConnect suggest.
 
view
download pdf
Biomarkers and Assay Development

Marking Safety

New biomarkers are being evaluated as a promising solution to the threat of sepsis, as Professor Christene Leiper at Onorach explores.
 
view
download pdf
Central Laboratory Competencies

Smooth Sailing

Dr Sarah Waelde and Dr Holger Schoeneborn at SYNLAB pharma institute discuss the importance of maintaining Good Clinical Practice throughout the clinical trial process.
 
view
download pdf
bullet
Outsourcing
Equipment Rental Considerations
Healthy Hiring

Robin Salter at KWIPPED and Valere Horath at Quipment explain what considerations need to be made when renting equipment for a clinical trial.

 
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

c-LEcta signs Europe sales and distribution agreement with VWR for c-LEcta’s DENARASE®

• DENARASE® is now available through VWR’s sales channels in Europe • VWR, part of Avantor, is a leading global provider of product and service solutions to laboratory and production customers • Cooperation harbors the potential for c-LEcta’s product to gain additional share in a highly dynamic market
More info >>

White Papers

Running Better Trials Taking an Intelligent Monitoring Approach

Bioclinica

When it comes to implementing a risk-based monitoring program, it is not just about reducing monitoring visits and doing less Source Document Verification (SDV). It’s about bringing together your people, a solid process, and the right technology to run a better trial. Success with risk-based monitoring requires the ability to make sense of the thousands, if not millions, of data points captured by multiple disparate sources in a clinical trial. With the sheer volume of data generated on a daily basis comes complexity. How does one make sense of it all? Information overload burdens even the most experienced study teams who struggle to understand which data matters most and what it means.
More info >>

Industry Events

4th Annual Genome Editing Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 4thAnnual Genome Editing Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement